IL-1R8 expression in DLBCL regulates NK cell recruitment and influences patient prognosis

Al-Mterin MA, Murshed K, Elkord E (2022) PD-1 expression, among other immune checkpoints, on tumor-infiltrating NK and NKT cells is associated with longer disease-free survival in treatment-naive CRC patients. [Journal Article]. Cancer Immunol Immunother. https://doi.org/10.1007/s00262-022-03337-8

Baecklund E, Smedby KE, Sutton LA, Askling J, Rosenquist R (2014) Lymphoma development in patients with autoimmune and inflammatory disorders--what are the driving forces? [Journal Article; Research Support, Non-U.S. Gov't; Review]. Semin Cancer Biol 24:61–70. https://doi.org/10.1016/j.semcancer.2013.12.001

Article  CAS  PubMed  Google Scholar 

Baker KJ, Houston A, Brint E (2019) IL-1 family members in cancer; two sides to every story[Journal Article; Research Support, Non-U.S. Gov't; Review]. Front Immunol 10:1197. https://doi.org/10.3389/fimmu.2019.01197

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bauman TM, Becka AJ, Sehgal PD, Huang W, Ricke WA (2015) SIGIRR/TIR8, an important regulator of TLR4 and IL-1R-mediated NF-kappaB activation, predicts biochemical recurrence after prostatectomy in low-grade prostate carcinomas. [Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't]. Hum Pathol 46(11):1744–1751. https://doi.org/10.1016/j.humpath.2015.07.015

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bhandari B, Basyal B, Sarao MS, Nookala V, Thein Y (2020) Prevalence of cancer in rheumatoid arthritis: epidemiological study based on the National Health and Nutrition Examination Survey (NHANES) [Journal Article]. Cureus 12(4):e7870. https://doi.org/10.7759/cureus.7870

Article  PubMed  PubMed Central  Google Scholar 

Bisheshar SK, De Ruiter EJ, Devriese LA, Willems SM (2020) The prognostic role of NK cells and their ligands in squamous cell carcinoma of the head and neck: a systematic review and meta-analysis [Journal Article; Meta-Analysis; Systematic Review]. Oncoimmunology 9(1):1747345. https://doi.org/10.1080/2162402X.2020.1747345

Article  PubMed  PubMed Central  Google Scholar 

Boraschi D, Italiani P, Weil S, Martin MU (2018) The family of the interleukin-1 receptors. [Journal Article; Research Support, Non-U.S. Gov't; Review]. Immunol Rev 281(1):197–232. https://doi.org/10.1111/imr.12606

Article  CAS  PubMed  Google Scholar 

Bruchard M, Spits H (2022) The role of ILC subsets in cancer. [Journal Article; Review]. Semin Immunol 61-64:101654. https://doi.org/10.1016/j.smim.2022.101654

Article  CAS  PubMed  Google Scholar 

Campesato LF, Silva A, Cordeiro L, Correa BR, Navarro F, Zanin RF, Marcola M, Inoue LT, Duarte ML, Molgora M, Pasqualini F, Massara M, Galante P, Barroso-Sousa R, Polentarutti N, Riva F, Costa ET, Mantovani A, Garlanda C, Camargo AA (2017) High IL-1R8 expression in breast tumors promotes tumor growth and contributes to impaired antitumor immunity [Journal Article]. Oncotarget 8(30):49470–49483. https://doi.org/10.18632/oncotarget.17713

Article  PubMed  PubMed Central  Google Scholar 

Goules AV, Argyropoulou OD, Pezoulas VC, Chatzis L, Critselis E, Gandolfo S, Ferro F, Binutti M, Donati V, Zandonella CS, Venetsanopoulou A, Zampeli E, Mavrommati M, Voulgari PV, Exarchos T, Mavragani CP, Baldini C, Skopouli FN, Fotiadis DI et al (2020) Primary Sjogren’s syndrome of early and late onset: distinct clinical phenotypes and lymphoma development [Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't]. Front Immunol 11:594096. https://doi.org/10.3389/fimmu.2020.594096

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guey B, Bodnar-Wachtel M, Drouillard A, Eberhardt A, Pratviel M, Goutagny N, Bendriss-Vermare N, Puisieux I, Caux C, Walzer T, Petrilli V (2020) Inflammasome deletion promotes anti-tumor NK cell function in an IL-1/IL-18 independent way in murine invasive breast cancer. [Journal Article]. Front. Oncol 10:1683. https://doi.org/10.3389/fonc.2020.01683

Article  Google Scholar 

Kienzl M, Hasenoehrl C, Valadez-Cosmes P, Maitz K, Sarsembayeva A, Sturm E, Heinemann A, Kargl J, Schicho R (2020) IL-33 reduces tumor growth in models of colorectal cancer with the help of eosinophils [Journal Article; Research Support, Non-U.S. Gov't]. Oncoimmunology 9(1):1776059. https://doi.org/10.1080/2162402X.2020.1776059

Article  PubMed  PubMed Central  Google Scholar 

Landskron G, De la Fuente LM, Dubois-Camacho K, Diaz-Jimenez D, Orellana-Serradell O, Romero D, Sepulveda SA, Salazar C, Parada-Venegas D, Quera R, Simian D, Gonzalez MJ, Lopez-Kostner F, Kronberg U, Abedrapo M, Gallegos I, Contreras HR, Pena C, Diaz-Araya G et al (2019) Interleukin 33/ST2 axis components are associated to desmoplasia, a metastasis-related factor in colorectal cancer [Journal Article; Research Support, Non-U.S. Gov't]. Front Immunol 10:1394. https://doi.org/10.3389/fimmu.2019.01394

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mantovani A, Barajon I, Garlanda C (2018) IL-1 and IL-1 regulatory pathways in cancer progression and therapy. [Journal Article; Research Support, Non-U.S. Gov't; Review]. Immunol Rev 281(1):57–61. https://doi.org/10.1111/imr.12614

Article  CAS  PubMed  PubMed Central  Google Scholar 

Molgora M, Barajon I, Mantovani A, Garlanda C (2016) Regulatory role of IL-1R8 in immunity and disease [Journal Article; Review]. Front Immunol 7:149. https://doi.org/10.3389/fimmu.2016.00149

Article  CAS  PubMed  PubMed Central  Google Scholar 

Molgora M, Supino D, Mantovani A, Garlanda C (2018) Tuning inflammation and immunity by the negative regulators IL-1R2 and IL-1R8. [Journal Article; Review]. Immunol Rev 281(1):233–247. https://doi.org/10.1111/imr.12609

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nold-Petry CA, Lo CY, Rudloff I, Elgass KD, Li S, Gantier MP, Lotz-Havla AS, Gersting SW, Cho SX, Lao JC, Ellisdon AM, Rotter B, Azam T, Mangan NE, Rossello FJ, Whisstock JC, Bufler P, Garlanda C, Mantovani A et al (2015) IL-37 requires the receptors IL-18Ralpha and IL-1R8 (SIGIRR) to carry out its multifaceted anti-inflammatory program upon innate signal transduction. [Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't]. Nat Immunol 16(4):354–365. https://doi.org/10.1038/ni.3103

Article  CAS  PubMed  Google Scholar 

Okoye I, Xu L, Motamedi M, Parashar P, Walker JW, Elahi S (2020) Galectin-9 expression defines exhausted T cells and impaired cytotoxic NK cells in patients with virus-associated solid tumors. [Journal Article; Research Support, Non-U.S. Gov't]. J Immunother Cancer 8(2). https://doi.org/10.1136/jitc-2020-001849

Qu X, Tang Y, Hua S (2018) Immunological approaches towards cancer and inflammation: a cross talk [Journal Article; Research Support, Non-U.S. Gov't; Review]. Front Immunol 9:563. https://doi.org/10.3389/fimmu.2018.00563

Article  CAS  PubMed  PubMed Central  Google Scholar 

Riva F, Filipe J, Fanelli A, Marconato L, Inglesi A, Scanziani E, Soldati S, Licenziato L, Comazzi S, Minoli L, Aresu L (2022) IL-1R8 downregulation and concomitant TLR7 and TLR9 upregulation are related to the pathogenesis of canine diffuse large B-cell lymphoma [Journal Article]. Vet Sci 9(5). https://doi.org/10.3390/vetsci9050209

Riva F, Ponzoni M, Supino D, Bertilaccio M, Polentarutti N, Massara M, Pasqualini F, Carriero R, Innocenzi A, Anselmo A, Veliz-Rodriguez T, Simonetti G, Anders HJ, Caligaris-Cappio F, Mantovani A, Muzio M, Garlanda C (2019) IL1R8 deficiency drives autoimmunity-associated lymphoma development. [Journal Article; Research Support, Non-U.S. Gov't]. Cancer. Immunol Res 7(6):874–885. https://doi.org/10.1158/2326-6066.CIR-18-0698

Article  CAS  Google Scholar 

Saetang J, Chonpathompikunlert P, Sretrirutchai S, Roongsawang N, Kayasut K, Voravuthikunchai SP, Sukketsiri W, Tipmanee V, Sangkhathat S (2020) Anti-cancer effect of engineered recombinant interleukin 18. [Journal Article]. Adv. Clin Exp Med 29(10):1135–1143. https://doi.org/10.17219/acem/126298

Article  Google Scholar 

Shaffer AL, Rosenwald A, Staudt LM (2002) Lymphoid malignancies: the dark side of B-cell differentiation. [Comparative Study; Journal Article; Review]. Nat Rev Immunol 2(12):920–932. https://doi.org/10.1038/nri953

Article  CAS  PubMed  Google Scholar 

Swerdlow, S. H., Resea, I. (2008). WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues: WHO classification of tumours of haematopoietic and lymphoid tissues.

Tan TT, Coussens LM (2007) Humoral immunity, inflammation and cancer. [Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.; Review]. Curr Opin Immunol 19(2):209–216. https://doi.org/10.1016/j.coi.2007.01.001

Article  CAS  PubMed  Google Scholar 

Vilia MG, Fonte E, Veliz RT, Tocchetti M, Ranghetti P, Scarfo L, Papakonstantinou N, Ntoufa S, Stamatopoulos K, Ghia P, Muzio M (2017) The inhibitory receptor toll interleukin-1R 8 (TIR8/IL-1R8/SIGIRR) is downregulated in chronic lymphocytic leukemia. [Journal Article]. Leuk Lymphoma 58(10):2419–2425. https://doi.org/10.1080/10428194.2017.1295142

Article  CAS  PubMed  Google Scholar 

Vodicka P, Klener P, Trneny M (2022) Diffuse large B-cell lymphoma (DLBCL): early patient management and emerging treatment options. [Journal Article; Review]. Onco Targets Ther 15:1481–1501. https://doi.org/10.2147/OTT.S326632

Article  PubMed  PubMed Central  Google Scholar 

Wang LH, Wang WM, Lin SH, Shieh CC (2019) Bidirectional relationship between systemic lupus erythematosus and non-Hodgkin’s lymphoma: a nationwide population-based study. [Journal Article; Research Support, Non-U.S. Gov't]. Rheumatology (Oxford) 58(7):1245–1249. https://doi.org/10.1093/rheumatology/kez011

Article  PubMed  Google Scholar 

Xiao H, Gulen MF, Qin J, Yao J, Bulek K, Kish D, Altuntas CZ, Wald D, Ma C, Zhou H, Tuohy VK, Fairchild RL, de la Motte C, Cua D, Vallance BA, Li X (2007) The Toll-interleukin-1 receptor member SIGIRR regulates colonic epithelial homeostasis, inflammation, and tumorigenesis. [Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't]. Immunity 26(4):461–475. https://doi.org/10.1016/j.immuni.2007.02.012

Article  CAS  PubMed  Google Scholar 

Yao X, Matosevic S (2021) Chemokine networks modulating natural killer cell trafficking to solid tumors. [Journal Article; Research Support, Non-U.S. Gov't; Review]. Cytokine Growth Factor Rev 59:36–45. https://doi.org/10.1016/j.cytogfr.2020.12.003

Article  CAS  PubMed  Google Scholar 

Yu L, Yang X, Xu C, Sun J, Fang Z, Pan H, Han W (2020) Comprehensive analysis of the expression and prognostic value of CXC chemokines in colorectal cancer. [Journal Article]. Int Immunopharmacol 89(Pt B):107077. https://doi.org/10.1016/j.intimp.2020.107077

Article  CAS  PubMed  Google Scholar 

Zeng X, Dong X, Ma Y, Yao J (2022) Chemokine (C-X-C motif) ligand 1 maintains the immune surveillance function of natural killer cells via the PDK2/mTOR signaling pathway. [Journal Article]. Cell Biol Toxicol. https://doi.org/10.1007/s10565-022-09708-2

Zhao JJ, Pan QZ, Pan K, Weng DS, Wang QJ, Li JJ, Lv L, Wang DD, Zheng HX, Jiang SS, Zhang XF, Xia JC (2014) Interleukin-37 mediates the antitumor activity in hepatocellular carcinoma: role for CD57+ NK cells [Journal Article; Research Support, Non-U.S. Gov't]. Sci Rep 4:5177. https://doi.org/10.1038/srep05177

Article  CAS  PubMed  PubMed Central 

留言 (0)

沒有登入
gif